To assess the extent to which these in vitro effects could be translated to an in vivo limb ischemia model, we used 129SV/WT mice (Nagy et al., 1993), which share the same origin as E14IV-ES cells and consequently C22-E14IV-MØs, thereby minimizing host immune reactions. This evidence concerns the gene MTR and limb ischemia.